SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328874. A total of 30 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $0 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,727,308 | $3,437,000 | 0.14% |
Monashee Investment Management LLC | 348,473 | $693,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 91,645 | $182,000 | 0.03% |
Ikarian Capital, LLC | 200,000 | $398,000 | 0.02% |
20/20 Capital Management, Inc. | 10,000 | $29,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 21,400 | $43,000 | 0.00% |
SEAVIEW INVESTMENT MANAGERS LLC | 1,221 | $2,000 | 0.00% |
VANGUARD GROUP INC | 337,529 | $671,000 | 0.00% |
TCI Wealth Advisors, Inc. | 2 | $0 | 0.00% |
UBS Group AG | 4,207 | $9,000 | 0.00% |